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ABSTRACT 
 
OBJECTIVE: The objective of this selective EBM review is to determine whether or not 
physical activity, when combined with androgen deprivation therapy, yields a better 
quality of life in survivors of prostate cancer. 
 
STUDEY DESIGN: Three randomized, controlled trials (RCTs) were found using the 
PubMed and Cochrane databases. The studies compared regular physical activity in men 
undergoing androgen deprivation therapy for prostate cancer. 
 
OUTCOMES MEASURED: The outcomes measured were self-reported quality of life 
surveys at different time intervals. 
 
RESULTS: Two out of the three studies demonstrated statistically significant 
improvement in reported quality of life during the exercise programs. The third study did 
not find significant increases in quality of life. 
 
CONCLUSIONS: Based off of the data collected, physical activity seems to be safe and 
effective in improving quality of life in men undergoing androgen deprivation therapy for 
prostate cancer. 
 
KEY WORDS: prostate cancer, androgen deprivation therapy, physical activity, quality 
of life  
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Introduction 
 The most common death from cancer in the male population, behind lung cancer, 
is prostate cancer.1 Prostate cancer is also the leading cause of cancer in men of all races 
and ethnicities.1 Prostate cancer is a very common type of cancer, typically treated with 
androgen deprivation therapy.2,3 Moreover, the diagnosis comes with a treatment plan that 
often decreases quality of life through adverse side effects. A few of these side effects 
include gain of fat mass, loss of muscle mass, urinary incontinence, erectile dysfunction, 
decreased quality of life, bowel dysfunction, and fatigue.2,3 Furthermore, males may be 
receiving long term treatment for up to two decades.2 This paper looks at three 
randomized controlled trials comparing the efficacy of aerobic exercise combined with 
androgen deprivation therapy in an effort to increase quality of life (QoL) in prostate 
cancer survivors.  
 The exact cause of prostate cancer is unknown, though increasing age, high 
consumption of dietary fat, and family history seem to play a major role.4 Although this 
disease crosses the spectrum of ethnicity, according to the CDC in the years 1999 to 2012, 
the highest prevalence was seen amongst black men, followed by Caucasian, Hispanic, 
American Indian, and Asian.5 Though symptoms can vary amongst men, most common 
symptoms of prostate cancer include back pain, urinary hesitancy, and hematuria.4  
 Standard screening measures include digital rectal exams and/or prostate specific 
antigen levels in the serum, although further research is being conducted about what the 
best screening method is.4 Digital rectal exams are a part of all physical exams for males 
between the ages of 40-70. Unfortunately, with the current prostate cancer screening 
methods, false-positives and false-negatives can occur. The usual methods used to treat 
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this condition include androgen deprivation therapy (ADT), chemotherapeutics, 
immunotherapy, external beam radiation therapy, brachytherapy, radionuclide therapy, or 
radical prostatectomy.2,3 Overall ADT has excellent outcomes, however, with it comes 
many associated side effects. This is especially in the elderly (>70), where testosterone 
may fail to recover fully.3  
 Prostate cancer statistics are well documented. According to the CDC, the total 
number of prostatectomy procedures in 2010 was 138,000.6 The CDC also reports the 
number of deaths from prostate cancer in 2013 alone, was 27,682.6 However, 2.9 million 
men in the United States have been diagnosed with prostate cancer at some point in their 
lives and are still alive.7 Prostate cancer is a disease predominantly associated with older 
men, with the average age being over 65.7 However, most prostate cancer survivors are 
not meeting the guidelines for physical activity.8 
 The cost of the treatment in 2012, averaged per patient per year $3,205 for 
prostectomy, $2,557 for brachytherapy, with the most costly treatment being the external 
beam therapy, averaging $6,412 annually.9 In 2013, the cost of androgen deprivation 
therapy was $1,100 for a three-month regime.10 
Overall outcomes are good, however we do see a decreased quality of life with 
both diagnosis and treatment.  
Objective 
 The objective of this evidence based medicine review is to determine whether 
physical activity, when combined with androgen deprivation therapy, yields a better 
quality of life in survivors of prostate cancer.  
Methods 
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 The studies that were included in this review consist of three randomized 
controlled trials (RCTs). The population consisted of male survivors of prostate cancer 
that had undergone or were currently undergoing androgen deprivation therapy. The 
intervention used was physical activity consisting of both resistance and aerobic exercise. 
The comparison included sedentary male survivors of prostate cancer that had already 
undergone or were undergoing androgen deprivation therapy.  
 The keywords used in the searches were “prostate cancer”, “physical activity”, 
and “androgen deprivation therapy.” All of the RCTs reviewed were published in peer-
reviewed articles, written in English, and found on the PubMed database. The articles 
were chosen based off relevance to the clinical question and were patient oriented 
outcomes (POEMs).  
 The inclusion criteria included men at least eighteen years of age that had 
received or were currently receiving androgen deprivation therapy.  The males were also 
sedentary, meaning that they had not done structured exercise under the oncology 
guidelines of 150 minutes of aerobic and twice resistance training sessions per week for 
at least 6 months prior.3 Bourke et al included men receiving long term ADT. Galvao et 
al sent surveys to subjects asking them to be apart of a study and required prior approval 
from the subject’s general practitioner (GP). McGowan included only males that lived in 
Alberta, Canada and were diagnosed between the years 2005 and 2009. Exclusion criteria 
included men with a comorbid condition that would affect exercise, especially unstable 
angina, uncontrolled hypertension, recent myocardial infarction, history of pacemaker, 
any neurologic disorder, and metastasis of primary prostate cancer.2 Subjects that were 
not cleared by their GP were also excluded.3  
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Table 1: Demographics and Characteristics of Included Studies  
 
Study Type # of 
patients 
Age 
(yrs) 
Inclusion 
Criteria 
Exclusion 
Criteria 
W/D Interventions 
Bourke, 
2014 
(1) 
RCT 100 71+/- 
6 yrs 
Sedentary 
men, men 
receiving long 
term ADT.  
Men with 
unstable 
angina, 
unctrolled 
HTN, recent 
MI, 
pacemakers, 
metastasis of 
primary CA 
32 12-week lifestyle 
intervention 
consisting of 
aerobic and 
resistance 
exercise.  
Galvao, 
2013 
(2) 
RCT 347 71.9 
+/- 5 
yrs 
Eligible 
patients that 
responded to 
anonymous 
questionnaire, 
clearance from 
their GP,  
No response, 
GP declined, 
travel 
constraints, 
already 
meeting 
exercise 
oncology 
guidelines, 
preexisting 
illness 
23 Resistance and 
aerobic exercise 
or printed 
educational 
material about 
physical activity 
McGowan, 
2013 
(3) 
RCT 423 47-89 At least 18 
years of age, 
must reside in 
Aleberta, 
Canada, 
diagnosed with 
prostate CA 
between 2005 
and 2009 
Patients that 
did not return 
completed 
inventory 
questionnaire  
120 Self-
administered 
implementation 
intention, 
telephone 
assisted 
intention, 
standard physical 
activity 
recommendation. 
Data measured at 
baseline, 1, and 3 
months.  
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Outcomes measured 
 The primary outcome measured in all three studies was quality of life. Bourke et 
al used the Functional Assessment of Cancer Therapy-Prostate (FACT-P) and Functional 
Assessment of Cancer Therapy-Fatigue (FACT-F) questionnaires at 12 weeks and 6 
months. Galvao et al utilized the Short Form-36 Health Survey to determine quality of 
life at baseline, 6 months, and 12 months. McGowan et al utilized both the FACT-P and 
the Short Form-36 Health Survey. 
Results 
 Bourke 2014 et al utilized 100 male patients, based off of the inclusion/exclusion 
criteria in Table 1, and implemented a 12-week aerobic and resistance exercise program 
with a follow up at 6 months. The trial’s median age was 71.2 Individuals were placed 
into a group in which they performed exercise under the guidance of an exercise 
physiologist compared to a usual care group.2 The usual care group will not be discussed 
any further in this paper. The exercise group performed thirty minutes of activity on 
stationary cycles, rowing ergometers, and treadmills at an intensity of 55-75% of their 
age predicted maximum heart rate.2 The men exercised twice per week for the first six 
weeks, and then once per week for the remaining six weeks, with recommendation of 
exercising on their own at least once more per week.2 The co-primary outcomes 
measured in the study were quality of life and change in diastolic blood pressure.2 QoL 
was measured via the FACT-P and FACT-F surveys.2 Clinically relevant increases in 
QoL were seen at the end of intervention, with a mean difference of 8.9 points at 95% 
confidence interval (CI), although sustained changes in QoL were not persistent at six 
months with a mean difference at 3.9 points at 95% CI on the FACT-F.2  
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Table 2. Data between intervention and control groups at 12 weeks and 6 months.2 
FACT – F 
Control 
(mean) 
Intervention 
(mean) 
Mean 
Difference 
P Value 
12 weeks 42.4 45.8 5.3 <0.001 
 6 months 41.9 43.5 3.9 0.007 
 
In Galvao 2013 et al, three hundred forty-seven men were invited via a letter of 
invitation from their oncologist to participate in the study. Subjects first needed to be 
cleared by a physician to participate, along with other inclusion/exclusion criteria in 
Table 1. The men were divided into two groups of either supervised exercise or physical 
activity with printed material based off of testosterone levels, age, whether disease 
relapse occurred, and waist circumference size.3 The supervised exercise group 
performed resistance and aerobic exercise twice per week for six months using standard 
weight room equipment (such as dumbbells and leg press machine) and under the 
supervision of an exercise physiologist.3 This group was also encouraged to exercise at 
least once per week on their own. Both groups in this study received a pedometer to track 
their steps. The printed exercise group was recommended one hundred fifty minutes per 
week of moderate physical activity and received an educational booklet. Quality of life 
was measured using the Short Form-36 Heath Survey at baseline, 6 months, and 1 year. 
From seven to twelve months was considered “the maintenance phase.”3 Data was 
analyzed using SPSS v.19; and analysis was intention to treat.3 The tests were two-tailed, 
with an alpha level of 0.05 and confidence interval of >95%.3 Significant increase in 
physical functioning at 6 months, with a p value of 0.006 and at 12 months, with a p 
value at 0.002 for the supervised exercise group were documented.3   
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TABLE 3. Physical Functioning between groups at 6 months and 12 months. 
 Mean change over 6 months Mean change over 12 months 
Physical Functioning 
M – 2.4 
P value = 0.006 
M - 3.5 
P value = 0.002 
    
 There were few severe adverse effects observed in the trial. Two participants 
dropped out due to back and knee pain, respectively. One participant died from lung 
cancer, during the maintenance phase although the cause of death was not associated with 
exercise. Another participant had a nonfatal myocardial infarction, also during the 
maintenance phase, and made a full recovery.  
McGowan 2013 et al incorporated 1,500 prostate cancer survivors residing in 
Alberta, Canada and diagnosed between 2005 and 2009. These participants were mailed 
questionnaires, and pending response, participated in the study.8 Subjects were placed 
into one of three groups; standard physical activity recommendation (SR), self-
administered implementation intention (SA), and telephone assisted (TA); using a 
computer generated, Graphpad Software program.8 Measures include medical 
characteristics such as date of diagnosis, disease stage, and current status of treatment.8 
Quality of life was measured using the short-form36 health survey.8 Analysis of 
covariance was used to examine differences in groups at month 3.8 Demographic and 
medical factors such as age, marital status, body mass index, education, and employment 
were documented as these indicators were all thought to play a role in physical activity 
behavior.8 The outcomes were measured at the third month only. In this study, there were 
no significant differences reported by subjects in quality of life between groups and no 
correlation between the factors listed above.   
Ridolfi 
ADT and Physical Activity 
 
8 
 
Table 4. Patient oriented outcomes between groups at month 3-post intervention.8  
 
 
 
 
 
 
Discussion  
 Although previous data has shown that resistance training can improve quality of 
life in younger men on short term ADT, Bourke et al was the first to study older 
sedentary men with similar increases in QoL.8 As many cancer survivors do not meet the 
standard exercise recommendations, the population studied is ideal because it represents 
the general public.2 Further evidence suggests, that ADT can cause cardiovascular 
disease, and physical activity could act as a preventative measure.2  
 The study by Bourke et al, is to date the largest lifestyle intervention RCT of 
sedentary men with advanced prostate cancer on ADT.2 The study found that tapered 
exercise as an intervention measure showed important changes in disease specific QoL. 
Although previous data has shown that resistance training can improve quality of life in 
younger men on short term ADT, Bourke et al was the first to study older sedentary men 
with similar increases in QoL.2,11 
 Galvao et al shows two important findings in their study. The first, six months of 
supervised exercise showed several important prognostic factors, which included 
improved cardio respiratory fitness, lower body physical function, self reported physical 
Between group 
Comparisons at 3 
months 
P value 
TA vs SR 
SA vs SR 
TA vs SA 
0.585 
0.226 
0.512 
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functioning, mental health and muscle strength.3 The second important finding, was that 
these findings were largely sustained in the following six-month home maintenance 
programs.3 This study showed that the findings of long-term prostate cancer survivors 
who were previously treated with ADT, showed improvements that had been observed at 
six months were also sustained at twelve months through home based maintenance 
programs.3 The discussion addressed that ADT can negatively affect muscle strength. 
This study showed muscle strength gains across a twelve month period with significant 
improvements for the exercise group.3 Although it is known that ADT causes adverse 
effects, this is the first study that demonstrates long-term prostate cancer survivors 
previously treated were able to increase their skeletal muscle with supervised exercise 
training.3 The study targeted a well-defined population, of long term older prostate cancer 
survivors, a group that has been difficult to enroll in such exercise research.3 Also 
included was a comprehensive series of physical fitness markers. A limitation of this 
study was the inclusion of men who were motivated to embark in an exercise program, 
this may not be representative of older men in this population.  
 McGowan et al concluded that their hypothesis was supported for the intention 
group. This group reported a significantly greater increase in physical activity compared 
to standard physical activity at a one-month interval. However the telephone-assisted 
group, did not show improvement. A similar limitation to Galvao et al was that the 
subject group seemed overwhelmingly interested in participating. The telephone assisted 
group received print materials but did not report better QoL during a six-month 
intervention period. A limitation of the telephone group, was some of the subjects after 
agreeing to participate, explained that they were unable to fulfill their agreement. Lastly 
Ridolfi 
ADT and Physical Activity 
 
10 
the physical activity was conducted over a very short time, therefore they were unable to 
show significance. 
In conclusion of the discussion two out of the three studies found that not only 
does the intervention of physical activity seem effective, but also it is relatively 
inexpensive, and with prior clearance from a healthcare provider, it is safe as well. 
Exercise is not covered under many insurance plans, however exercise is accessible to 
anyone at their home with proper instruction.  
 Currently, androgen deprivation therapy is mainly used only for prostate cancer 
treatments. There are no relative black box warnings, but some studies have shown 
correlations between fatal cardiovascular events such as myocardial infarcts in long-term 
studies.12  
Conclusion 
 This selective EBM review investigated three randomized controlled trials 
comparing quality of life and exercise in men who had received or were currently 
receiving androgen deprivation therapy. In conclusion, this systematic review 
demonstrates that physical activity is effective in improving the quality of life in patients 
that had undergone androgen deprivation therapy. Two out of the three studies included 
have shown clinically significant data proving that routine physical activity increases 
quality of life. Based off of these statistics, physical activity should be strongly 
considered for those receiving androgen deprivation therapy to increase their quality of 
life.  
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